Delivery Order SPE2DB20D3111-SPE2DB24FA7BX

Award Date 3/25/24
Potential Completion Date 3/26/24
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,533.04 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a performance period through March 4, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA, valued up to $999,999,999.00, to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract, valued at $13,933.44, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,760.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $8,708.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $13,933.44 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this order, which is part...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,161.12 contract is for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,741.68 and a completion date of February 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,675.35, is for the provision of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,483.36 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,958.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA7BX
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,902.80 contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 6/24/24, 9:09 AM